P09.36 A new therapeutic strategy for newly diagnosed glioblastoma patients: hypofractionated stereotactic radiation therapy (HSRT) delivered in 15 fractions respect to standard fractionation in 30 fractions, with concomitant temozolomide chemotherapy - A phase II study

Introduction: The standard of care, for newly diagnosed glioblastoma multiforme (GBM), consists of surgical resection, followed by radiotherapy with concurrent and adjuvant Temozolomide. Results are still unsatisfactory. Aim of this prospective study was to evaluate outcome of newly diagnosed GBM pa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Navarria, P., Pessina, F., Tomatis, S., Simonelli, M., Santoro, A., Ascolese, A., Clerici, E., Rossi, M., Bello, L., Scorsetti, M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
POSTER PRESENTATIONS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464241/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.292
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak